{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:37:48Z","timestamp":1789659468331,"version":"4.0.1"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11302-023-09981-8","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T05:02:56Z","timestamp":1701406976000},"page":"83-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Purinergic signaling in the battlefield of viral infections"],"prefix":"10.1007","volume":"21","author":[{"given":"Nayara","family":"Carvalho-Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna Dias","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo Baggio","family":"Savio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson","family":"Coutinho-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"31","key":"9981_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01506215","volume":"17","author":"K Lohmann","year":"1929","unstructured":"Lohmann K (1929) \u00fcber die Pyrophosphatfraktion im Muskel. Naturwissenschaften 17(31):1. https:\/\/doi.org\/10.1007\/BF01506215","journal-title":"Naturwissenschaften"},{"issue":"4","key":"9981_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1476-5381.1970.tb10646.x","volume":"40","author":"G Burnstock","year":"1970","unstructured":"Burnstock G, Campbell G, Satchell D, Smythe A (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40(4):668\u2013688. https:\/\/doi.org\/10.1111\/j.1476-5381.1970.tb10646.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9981_CR3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-6997(25)06930-3","volume":"24","author":"G Burnstock","year":"1972","unstructured":"Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509\u2013581 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4404211","journal-title":"Pharmacol Rev"},{"key":"9981_CR4","doi-asserted-by":"publisher","first-page":"114405","DOI":"10.1016\/j.bcp.2021.114405","volume":"187","author":"R Coutinho-Silva","year":"2021","unstructured":"Coutinho-Silva R, Savio LEB (2021) Purinergic signalling in host innate immune defence against intracellular pathogens. Biochem Pharmacol 187:114405. https:\/\/doi.org\/10.1016\/j.bcp.2021.114405","journal-title":"Biochem Pharmacol"},{"key":"9981_CR5","doi-asserted-by":"publisher","first-page":"109541","DOI":"10.1016\/j.neuropharm.2023.109541","volume":"233","author":"P Mut-Arbona","year":"2023","unstructured":"Mut-Arbona P, Sperlagh B (2023) P2 receptor-mediated signaling in the physiological and pathological brain: from development to aging and disease. Neuropharmacology 233:109541. https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109541","journal-title":"Neuropharmacology"},{"key":"9981_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2018.11.006","volume":"205","author":"AL Giuliani","year":"2019","unstructured":"Giuliani AL, Sarti AC, Di Virgilio F (2019) Extracellular nucleotides and nucleosides as signalling molecules. Immunol Lett 205:16\u201324. https:\/\/doi.org\/10.1016\/j.imlet.2018.11.006","journal-title":"Immunol Lett"},{"issue":"1","key":"9981_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41467-023-37413-z","volume":"14","author":"Z He","year":"2023","unstructured":"He Z, Zhao Y, Rau MJ, Fitzpatrick JAJ, Sah R, Hu H, Yuan P (2023) Structural and functional analysis of human pannexin 2 channel. Nat Commun 14(1):1712. https:\/\/doi.org\/10.1038\/s41467-023-37413-z","journal-title":"Nat Commun"},{"issue":"26","key":"9981_CR8","doi-asserted-by":"publisher","first-page":"15735","DOI":"10.1073\/pnas.95.26.15735","volume":"95","author":"ML Cotrina","year":"1998","unstructured":"Cotrina ML, Lin JH, Alves-Rodrigues A, Liu S, Li J, Azmi-Ghadimi H, Kang J, Naus CC, Nedergaard M (1998) Connexins regulate calcium signaling by controlling ATP release. Proc Natl Acad Sci U S A 95(26):15735\u201315740. https:\/\/doi.org\/10.1073\/pnas.95.26.15735","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9981_CR9","doi-asserted-by":"publisher","unstructured":"Dosch M, Gerber J, Jebbawi F, Beldi G (2018) Mechanisms of ATP release by inflammatory cells. Int J Mol Sci 19(4). https:\/\/doi.org\/10.3390\/ijms19041222","DOI":"10.3390\/ijms19041222"},{"issue":"3","key":"9981_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11302-012-9304-9","volume":"8","author":"ER Lazarowski","year":"2012","unstructured":"Lazarowski ER (2012) Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8(3):359\u2013373. https:\/\/doi.org\/10.1007\/s11302-012-9304-9","journal-title":"Purinergic Signal"},{"key":"9981_CR11","doi-asserted-by":"publisher","unstructured":"Spari D, Beldi G (2020) Extracellular ATP as an inter-kingdom signaling molecule: release mechanisms by bacteria and its implication on the host. Int J Mol Sci 21(15). https:\/\/doi.org\/10.3390\/ijms21155590","DOI":"10.3390\/ijms21155590"},{"issue":"11","key":"9981_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/bph.15005","volume":"177","author":"KA Jacobson","year":"2020","unstructured":"Jacobson KA, Delicado EG, Gachet C, Kennedy C, von Kugelgen I, Li B, Miras-Portugal MT, Novak I, Schoneberg T, Perez-Sen R, Thor D, Wu B, Yang Z, Muller CE (2020) Update of P2Y receptor pharmacology: IUPHAR review 27. Br J Pharmacol 177(11):2413\u20132433. https:\/\/doi.org\/10.1111\/bph.15005","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9981_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bph.15299","volume":"178","author":"P Illes","year":"2021","unstructured":"Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F (2021) Update of P2X receptor properties and their pharmacology: IUPHAR review 30. Br J Pharmacol 178(3):489\u2013514. https:\/\/doi.org\/10.1111\/bph.15299","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9981_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, AP IJ, Jacobson KA, Linden J, Muller CE (2011) International union of basic and clinical pharmacology. LXXXI Nomenclature and classification of adenosine receptors--an update. Pharmacol Rev 63(1):1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285","journal-title":"Pharmacol Rev"},{"key":"9981_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2019.02.005","volume":"47","author":"LEB Savio","year":"2019","unstructured":"Savio LEB, Coutinho-Silva R (2019) Immunomodulatory effects of P2X7 receptor in intracellular parasite infections. Curr Opin Pharmacol 47:53\u201358. https:\/\/doi.org\/10.1016\/j.coph.2019.02.005","journal-title":"Curr Opin Pharmacol"},{"key":"9981_CR16","doi-asserted-by":"publisher","first-page":"1179723","DOI":"10.3389\/fphar.2023.1179723","volume":"14","author":"VS Alves","year":"2023","unstructured":"Alves VS, da Silva JP, Rodrigues FC, Araujo SMB, Gouvea AL, Leite-Aguiar R, Santos S, da Silva MSP, Ferreira FS, Marques EP, Dos Passos B, Maron-Gutierrez T, Kurtenbach E, da Costa R, Figueiredo CP, Wyse ATS, Coutinho-Silva R, Savio LEB (2023) P2X7 receptor contributes to long-term neuroinflammation and cognitive impairment in sepsis-surviving mice. Front Pharmacol 14:1179723. https:\/\/doi.org\/10.3389\/fphar.2023.1179723","journal-title":"Front Pharmacol"},{"issue":"4","key":"9981_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11302-021-09807-5","volume":"17","author":"Z Zhou","year":"2021","unstructured":"Zhou Z (2021) Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction. Purinergic Signal 17(4):705\u2013712. https:\/\/doi.org\/10.1007\/s11302-021-09807-5","journal-title":"Purinergic Signal"},{"key":"9981_CR18","doi-asserted-by":"publisher","unstructured":"Querio G, Antoniotti S, Geddo F, Levi R, Gallo MP (2022) Trimethylamine N-oxide (TMAO) impairs purinergic induced intracellular calcium increase and nitric oxide release in endothelial cells. Int J Mol Sci 23(7). https:\/\/doi.org\/10.3390\/ijms23073982","DOI":"10.3390\/ijms23073982"},{"issue":"2","key":"9981_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jcb.30165","volume":"123","author":"YH Chen","year":"2022","unstructured":"Chen YH, Hsueh KK, Chu PW, Chen SK (2022) AMP-activated protein kinase mediates lipopolysaccharide-induced proinflammatory responses and elevated bone resorption in differentiated osteoclasts. J Cell Biochem 123(2):275\u2013288. https:\/\/doi.org\/10.1002\/jcb.30165","journal-title":"J Cell Biochem"},{"key":"9981_CR20","doi-asserted-by":"publisher","first-page":"651740","DOI":"10.3389\/fimmu.2021.651740","volume":"12","author":"PA Borges","year":"2021","unstructured":"Borges PA, Waclawiak I, Georgii JL, Fraga-Junior VDS, Barros JF, Lemos FS, Russo-Abrahao T, Saraiva EM, Takiya CM, Coutinho-Silva R, Penido C, Mermelstein C, Meyer-Fernandes JR, Canto FB, Neves JS, Melo PA, Canetti C, Benjamim CF (2021) Adenosine diphosphate improves wound healing in diabetic mice through P2Y(12) receptor activation. Front Immunol 12:651740. https:\/\/doi.org\/10.3389\/fimmu.2021.651740","journal-title":"Front Immunol"},{"issue":"1","key":"9981_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11302-021-09838-y","volume":"18","author":"N Eberhardt","year":"2022","unstructured":"Eberhardt N, Bergero G, Mazzocco Mariotta YL, Aoki MP (2022) Purinergic modulation of the immune response to infections. Purinergic Signal 18(1):93\u2013113. https:\/\/doi.org\/10.1007\/s11302-021-09838-y","journal-title":"Purinergic Signal"},{"key":"9981_CR22","doi-asserted-by":"publisher","first-page":"114322","DOI":"10.1016\/j.bcp.2020.114322","volume":"187","author":"H Zimmermann","year":"2021","unstructured":"Zimmermann H (2021) History of ectonucleotidases and their role in purinergic signaling. Biochem Pharmacol 187:114322. https:\/\/doi.org\/10.1016\/j.bcp.2020.114322","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"9981_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783(5):673\u2013694. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.024","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9981_CR24","first-page":"43","volume":"28","author":"R Dahlquist","year":"1970","unstructured":"Dahlquist R, Diamant B (1970) Further observations on ATP-induced histamine release from rat mast cells. Acta Pharmacol Toxicol (Copenh) 28(1):43 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4103483","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"9981_CR25","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.coph.2022.102331","volume":"68","author":"D Kobayashi","year":"2023","unstructured":"Kobayashi D, Umemoto E, Miyasaka M (2023) The role of extracellular ATP in homeostatic immune cell migration. Curr Opin Pharmacol 68:102331. https:\/\/doi.org\/10.1016\/j.coph.2022.102331","journal-title":"Curr Opin Pharmacol"},{"key":"9981_CR26","doi-asserted-by":"publisher","unstructured":"Ren W, Rubini P, Tang Y, Engel T, Illes P (2021) Inherent P2X7 receptors regulate macrophage functions during inflammatory diseases. Int J Mol Sci 23(1). https:\/\/doi.org\/10.3390\/ijms23010232","DOI":"10.3390\/ijms23010232"},{"issue":"4","key":"9981_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G, Boeynaems JM (2014) Purinergic signalling and immune cells. Purinergic Signal 10(4):529\u2013564. https:\/\/doi.org\/10.1007\/s11302-014-9427-2","journal-title":"Purinergic Signal"},{"issue":"12","key":"9981_CR28","doi-asserted-by":"publisher","first-page":"e1183","DOI":"10.1097\/CCM.0000000000003446","volume":"46","author":"AH Lee","year":"2018","unstructured":"Lee AH, Ledderose C, Li X, Slubowski CJ, Sueyoshi K, Staudenmaier L, Bao Y, Zhang J, Junger WG (2018) Adenosine triphosphate release is required for toll-like receptor-induced monocyte\/macrophage activation, inflammasome signaling, interleukin-1beta production, and the host immune response to infection. Crit Care Med 46(12):e1183\u2013e1189. https:\/\/doi.org\/10.1097\/CCM.0000000000003446","journal-title":"Crit Care Med"},{"issue":"11","key":"9981_CR29","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1182\/blood-2013-04-496216","volume":"122","author":"HB Cohen","year":"2013","unstructured":"Cohen HB, Briggs KT, Marino JP, Ravid K, Robson SC, Mosser DM (2013) TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses. Blood 122(11):1935\u20131945. https:\/\/doi.org\/10.1182\/blood-2013-04-496216","journal-title":"Blood"},{"issue":"5","key":"9981_CR30","doi-asserted-by":"publisher","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","volume":"318","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, Sarti AC, Coutinho-Silva R (2020) Purinergic signaling, DAMPs, and inflammation. Am J Physiol Cell Physiol 318(5):C832\u2013C835. https:\/\/doi.org\/10.1152\/ajpcell.00053.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"9981_CR31","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013\u20131067. https:\/\/doi.org\/10.1152\/physrev.00015.2002","journal-title":"Physiol Rev"},{"key":"9981_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2015.07.032","volume":"104","author":"C Habermacher","year":"2016","unstructured":"Habermacher C, Dunning K, Chataigneau T, Grutter T (2016) Molecular structure and function of P2X receptors. Neuropharmacology 104:18\u201330. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.032","journal-title":"Neuropharmacology"},{"key":"9981_CR33","doi-asserted-by":"publisher","first-page":"114361","DOI":"10.1016\/j.bcp.2020.114361","volume":"187","author":"I von Kugelgen","year":"2021","unstructured":"von Kugelgen I (2021) Molecular pharmacology of P2Y receptor subtypes. Biochem Pharmacol 187:114361. https:\/\/doi.org\/10.1016\/j.bcp.2020.114361","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"9981_CR34","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1096\/fj.14-268714","volume":"29","author":"A Franceschini","year":"2015","unstructured":"Franceschini A, Capece M, Chiozzi P, Falzoni S, Sanz JM, Sarti AC, Bonora M, Pinton P, Di Virgilio F (2015) The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J 29(6):2450\u20132461. https:\/\/doi.org\/10.1096\/fj.14-268714","journal-title":"FASEB J"},{"issue":"5","key":"9981_CR35","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1074\/jbc.M608083200","volume":"282","author":"CM Cruz","year":"2007","unstructured":"Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282(5):2871\u20132879. https:\/\/doi.org\/10.1074\/jbc.M608083200","journal-title":"J Biol Chem"},{"issue":"6","key":"9981_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/cmi.12089","volume":"15","author":"CH Choi","year":"2013","unstructured":"Choi CH, Spooner R, DeGuzman J, Koutouzis T, Ojcius DM, Yilmaz O (2013) Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor\/NADPH-oxidase signalling and contributes to persistence. Cell Microbiol 15(6):961\u2013976. https:\/\/doi.org\/10.1111\/cmi.12089","journal-title":"Cell Microbiol"},{"issue":"7","key":"9981_CR37","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","volume":"176","author":"D Ferrari","year":"2006","unstructured":"Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176(7):3877\u20133883. https:\/\/doi.org\/10.4049\/jimmunol.176.7.3877","journal-title":"J Immunol"},{"issue":"19","key":"9981_CR38","doi-asserted-by":"publisher","first-page":"8041","DOI":"10.1073\/pnas.0611496104","volume":"104","author":"JA Duncan","year":"2007","unstructured":"Duncan JA, Bergstralh DT, Wang Y, Willingham SB, Ye Z, Zimmermann AG, Ting JP (2007) Cryopyrin\/NALP3 binds ATP\/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci U S A 104(19):8041\u20138046. https:\/\/doi.org\/10.1073\/pnas.0611496104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9981_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397\u2013411. https:\/\/doi.org\/10.1038\/nri3452","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9981_CR40","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ajpath.2019.01.001","volume":"189","author":"ACA Moreira-Souza","year":"2019","unstructured":"Moreira-Souza ACA, Rangel TP, Silva S, Figliuolo VR, Savio LEB, Schmitz F, Takiya CM, Wyse ATS, Vommaro RC, Coutinho-Silva R (2019) Disruption of purinergic receptor P2X7 signaling increases susceptibility to cerebral toxoplasmosis. Am J Pathol 189(4):730\u2013738. https:\/\/doi.org\/10.1016\/j.ajpath.2019.01.001","journal-title":"Am J Pathol"},{"issue":"2","key":"9981_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11302-016-9544-1","volume":"13","author":"VR Figliuolo","year":"2017","unstructured":"Figliuolo VR, Chaves SP, Savio LEB, Thorstenberg MLP, Machado Salles E, Takiya CM, D\u2019Imperio-Lima MR, de Matos Guedes HL, Rossi-Bergmann B, Coutinho-Silva R (2017) The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control. Purinergic Signal 13(2):143\u2013152. https:\/\/doi.org\/10.1007\/s11302-016-9544-1","journal-title":"Purinergic Signal"},{"issue":"1","key":"9981_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.imbio.2018.10.008","volume":"224","author":"CLC Almeida-da-Silva","year":"2019","unstructured":"Almeida-da-Silva CLC, Ramos-Junior ES, Morandini AC, Rocha GDC, Marinho Y, Tamura AS, de Andrade KQ, Bellio M, Savio LEB, Scharfstein J, Ojcius DM, Coutinho-Silva R (2019) P2X7 receptor-mediated leukocyte recruitment and Porphyromonas gingivalis clearance requires IL-1beta production and autocrine IL-1 receptor activation. Immunobiology 224(1):50\u201359. https:\/\/doi.org\/10.1016\/j.imbio.2018.10.008","journal-title":"Immunobiology"},{"issue":"9","key":"9981_CR43","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1096\/fj.15-272450","volume":"29","author":"B Csoka","year":"2015","unstructured":"Csoka B, Nemeth ZH, Toro G, Idzko M, Zech A, Koscso B, Spolarics Z, Antonioli L, Cseri K, Erdelyi K, Pacher P, Hasko G (2015) Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J 29(9):3626\u20133637. https:\/\/doi.org\/10.1096\/fj.15-272450","journal-title":"FASEB J"},{"key":"9981_CR44","doi-asserted-by":"publisher","unstructured":"Csoka B, Nemeth ZH, Szabo I, Davies DL, Varga ZV, Paloczi J, Falzoni S, Di Virgilio F, Muramatsu R, Yamashita T, Pacher P, Hasko G (2018) Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI Insight 3(11). https:\/\/doi.org\/10.1172\/jci.insight.99431","DOI":"10.1172\/jci.insight.99431"},{"issue":"8","key":"9981_CR45","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1007\/s12035-016-0168-9","volume":"54","author":"LEB Savio","year":"2017","unstructured":"Savio LEB, Andrade MGJ, de Andrade MP, Santana PT, Moreira-Souza ACA, Kolling J, Longoni A, Feldbrugge L, Wu Y, Wyse ATS, Robson SC, Coutinho-Silva R (2017) P2X7 Receptor signaling contributes to sepsis-associated brain dysfunction. Mol Neurobiol 54(8):6459\u20136470. https:\/\/doi.org\/10.1007\/s12035-016-0168-9","journal-title":"Mol Neurobiol"},{"key":"9981_CR46","doi-asserted-by":"publisher","first-page":"672472","DOI":"10.3389\/fcimb.2021.672472","volume":"11","author":"I Santiago-Carvalho","year":"2021","unstructured":"Santiago-Carvalho I, de Almeida-Santos G, Bomfim CCB, de Souza PC, Silva J, de Melo BMS, Amaral EP, Cione MVP, Lasunskaia E, Hirata MH, Alves-Filho JCF, Nakaya HI, Alvarez JM, D'Imperio Lima MR (2021) P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis. Front Cell Infect Microbiol 11:672472. https:\/\/doi.org\/10.3389\/fcimb.2021.672472","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"9981_CR47","doi-asserted-by":"publisher","first-page":"e1004188","DOI":"10.1371\/journal.ppat.1004188","volume":"10","author":"EP Amaral","year":"2014","unstructured":"Amaral EP, Ribeiro SC, Lanes VR, Almeida FM, de Andrade MR, Bomfim CC, Salles EM, Bortoluci KR, Coutinho-Silva R, Hirata MH, Alvarez JM, Lasunskaia EB, D\u2019Imperio-Lima MR (2014) Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog 10(7):e1004188. https:\/\/doi.org\/10.1371\/journal.ppat.1004188","journal-title":"PLoS Pathog"},{"issue":"4","key":"9981_CR48","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4049\/jimmunol.1700187","volume":"199","author":"C Zhang","year":"2017","unstructured":"Zhang C, He H, Wang L, Zhang N, Huang H, Xiong Q, Yan Y, Wu N, Ren H, Han H, Liu M, Qian M, Du B (2017) Virus-triggered ATP release limits viral replication through facilitating IFN-beta production in a P2X7-dependent manner. J Immunol 199(4):1372\u20131381. https:\/\/doi.org\/10.4049\/jimmunol.1700187","journal-title":"J Immunol"},{"issue":"7","key":"9981_CR49","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.imbio.2016.02.003","volume":"221","author":"G Correa","year":"2016","unstructured":"Correa G, Lindenberg CD, Fernandes-Santos C, Gandini M, Petitinga Paiva F, Coutinho-Silva R, Kubelka CF (2016) The purinergic receptor P2X7 role in control of dengue virus-2 infection and cytokine\/chemokine production in infected human monocytes. Immunobiology 221(7):794\u2013802. https:\/\/doi.org\/10.1016\/j.imbio.2016.02.003","journal-title":"Immunobiology"},{"issue":"1","key":"9981_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12931-020-01555-1","volume":"21","author":"Y Kamiya","year":"2020","unstructured":"Kamiya Y, Fujisawa T, Katsumata M, Yasui H, Suzuki Y, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Setou M, Ito M, Suzuki T, Ikegami K, Suda T (2020) Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium. Respir Res 21(1):282. https:\/\/doi.org\/10.1186\/s12931-020-01555-1","journal-title":"Respir Res"},{"issue":"19","key":"9981_CR51","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1111\/bph.14787","volume":"176","author":"S Rosli","year":"2019","unstructured":"Rosli S, Kirby FJ, Lawlor KE, Rainczuk K, Drummond GR, Mansell A, Tate MD (2019) Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection. Br J Pharmacol 176(19):3834\u20133844. https:\/\/doi.org\/10.1111\/bph.14787","journal-title":"Br J Pharmacol"},{"key":"9981_CR52","doi-asserted-by":"publisher","unstructured":"Lee VH, Ermler ME, Schotsaert M, Gonzalez MG, Gillespie V, Lim JK, Garcia-Sastre A (2017) Contribution of the purinergic receptor P2X7 to development of lung immunopathology during influenza virus infection. mBio 8(2). https:\/\/doi.org\/10.1128\/mBio.00229-17","DOI":"10.1128\/mBio.00229-17"},{"issue":"4","key":"9981_CR53","doi-asserted-by":"publisher","first-page":"e35812","DOI":"10.1371\/journal.pone.0035812","volume":"7","author":"BH Lee","year":"2012","unstructured":"Lee BH, Hwang DM, Palaniyar N, Grinstein S, Philpott DJ, Hu J (2012) Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection. PLoS One 7(4):e35812. https:\/\/doi.org\/10.1371\/journal.pone.0035812","journal-title":"PLoS One"},{"issue":"1","key":"9981_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12974-019-1466-8","volume":"16","author":"F Zhou","year":"2019","unstructured":"Zhou F, Liu X, Gao L, Zhou X, Cao Q, Niu L, Wang J, Zuo D, Li X, Yang Y, Hu M, Yu Y, Tang R, Lee BH, Choi BW, Wang Y, Izumiya Y, Xue M, Zheng K, Gao D (2019) HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K\/Akt and ERK MAPK pathways. J Neuroinflammation 16(1):71. https:\/\/doi.org\/10.1186\/s12974-019-1466-8","journal-title":"J Neuroinflammation"},{"issue":"1","key":"9981_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11302-017-9594-z","volume":"14","author":"Z Yi","year":"2018","unstructured":"Yi Z, Xie L, Zhou C, Yuan H, Ouyang S, Fang Z, Zhao S, Jia T, Zou L, Wang S, Xue Y, Yi Z, Gao Y, Li G, Liu S, Xu H, Xu C, Zhang C, Liang S (2018) P2Y(12) receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2',3'-dideoxycytidine. Purinergic Signal 14(1):47\u201358. https:\/\/doi.org\/10.1007\/s11302-017-9594-z","journal-title":"Purinergic Signal"},{"key":"9981_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainresbull.2017.09.006","volume":"135","author":"B Wu","year":"2017","unstructured":"Wu B, Peng L, Xie J, Zou L, Zhu Q, Jiang H, Yi Z, Wang S, Xue Y, Gao Y, Li G, Liu S, Zhang C, Li G, Liang S, Xiong H (2017) The P2X(7) receptor in dorsal root ganglia is involved in HIV gp120-associated neuropathic pain. Brain Res Bull 135:25\u201332. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.09.006","journal-title":"Brain Res Bull"},{"issue":"9","key":"9981_CR57","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1084\/jem.20101805","volume":"208","author":"C Seror","year":"2011","unstructured":"Seror C, Melki MT, Subra F, Raza SQ, Bras M, Saidi H, Nardacci R, Voisin L, Paoletti A, Law F, Martins I, Amendola A, Abdul-Sater AA, Ciccosanti F, Delelis O, Niedergang F, Thierry S, Said-Sadier N, Lamaze C et al (2011) Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med 208(9):1823\u20131834. https:\/\/doi.org\/10.1084\/jem.20101805","journal-title":"J Exp Med"},{"issue":"25","key":"9981_CR58","doi-asserted-by":"publisher","first-page":"E3265","DOI":"10.1073\/pnas.1500656112","volume":"112","author":"F Graziano","year":"2015","unstructured":"Graziano F, Desdouits M, Garzetti L, Podini P, Alfano M, Rubartelli A, Furlan R, Benaroch P, Poli G (2015) Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages. Proc Natl Acad Sci U S A 112(25):E3265\u2013E3273. https:\/\/doi.org\/10.1073\/pnas.1500656112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9981_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fphar.2020.00096","volume":"11","author":"JM Taylor","year":"2020","unstructured":"Taylor JM, Bortolotti D, Marci R, Caselli E, Falzoni S, De Marchi E, Di Virgilio F, Rizzo R, Adinolfi E (2020) The P2X7 Receptor 489C>T gain of function polymorphism favors HHV-6A infection and associates with female idiopathic infertility. Front Pharmacol 11:96. https:\/\/doi.org\/10.3389\/fphar.2020.00096","journal-title":"Front Pharmacol"},{"issue":"12","key":"9981_CR60","doi-asserted-by":"publisher","first-page":"e15784","DOI":"10.1371\/journal.pone.0015784","volume":"5","author":"JM Taylor","year":"2010","unstructured":"Taylor JM, Han Z (2010) Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus. PLoS One 5(12):e15784. https:\/\/doi.org\/10.1371\/journal.pone.0015784","journal-title":"PLoS One"},{"issue":"1","key":"9981_CR61","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","volume":"6","author":"JW Schoggins","year":"2019","unstructured":"Schoggins JW (2019) Interferon-stimulated genes: what do they all do? Annu Rev Virol 6(1):567\u2013584. https:\/\/doi.org\/10.1146\/annurev-virology-092818-015756","journal-title":"Annu Rev Virol"},{"key":"9981_CR62","doi-asserted-by":"publisher","unstructured":"Saez PJ, Vargas P, Shoji KF, Harcha PA, Lennon-Dumenil AM, Saez JC (2017) ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X(7) receptors. Sci Signal 10(506). https:\/\/doi.org\/10.1126\/scisignal.aah7107","DOI":"10.1126\/scisignal.aah7107"},{"issue":"5","key":"9981_CR63","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/JLB.2RU0421-226RR","volume":"112","author":"AVP Alberto","year":"2022","unstructured":"Alberto AVP, Ferreira N, Bonavita AGC, Nihei OK, Farias FP, Bisaggio RDC, Albuquerque C, Savino W, Coutinho-Silva R, Persechini PM, Alves LA (2022) Physiologic roles of P2 receptors in leukocytes. J Leukoc Biol 112(5):983\u20131012. https:\/\/doi.org\/10.1002\/JLB.2RU0421-226RR","journal-title":"J Leukoc Biol"},{"issue":"8","key":"9981_CR64","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.4049\/jimmunol.1303343","volume":"194","author":"CY Tsai","year":"2015","unstructured":"Tsai CY, Liong KH, Gunalan MG, Li N, Lim DS, Fisher DA, MacAry PA, Leo YS, Wong SC, Puan KJ, Wong SB (2015) Type I IFNs and IL-18 regulate the antiviral response of primary human gammadelta T cells against dendritic cells infected with dengue virus. J Immunol 194(8):3890\u20133900. https:\/\/doi.org\/10.4049\/jimmunol.1303343","journal-title":"J Immunol"},{"issue":"7","key":"9981_CR65","doi-asserted-by":"publisher","first-page":"2003895","DOI":"10.1002\/advs.202003895","volume":"8","author":"F Lisi","year":"2021","unstructured":"Lisi F, Zelikin AN, Chandrawati R (2021) Nitric oxide to fight viral infections. Adv Sci (Weinh) 8(7):2003895. https:\/\/doi.org\/10.1002\/advs.202003895","journal-title":"Adv Sci (Weinh)"},{"issue":"Suppl 1","key":"9981_CR66","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.33549\/physiolres.934404","volume":"69","author":"H Pedan","year":"2020","unstructured":"Pedan H, Janosova V, Hajtman A, Calkovsky V (2020) Non-reflex defense mechanisms of upper airway mucosa: possible clinical application. Physiol Res 69(Suppl 1):S55\u2013S67. https:\/\/doi.org\/10.33549\/physiolres.934404","journal-title":"Physiol Res"},{"issue":"8","key":"9981_CR67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","volume":"42","author":"R Karki","year":"2021","unstructured":"Karki R, Kanneganti TD (2021) The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects. Trends Immunol 42(8):681\u2013705. https:\/\/doi.org\/10.1016\/j.it.2021.06.001","journal-title":"Trends Immunol"},{"key":"9981_CR68","doi-asserted-by":"publisher","first-page":"659419","DOI":"10.3389\/fimmu.2021.659419","volume":"12","author":"S Yuan","year":"2021","unstructured":"Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL (2021) Quantification of cytokine storms during virus infections. Front Immunol 12:659419. https:\/\/doi.org\/10.3389\/fimmu.2021.659419","journal-title":"Front Immunol"},{"key":"9981_CR69","doi-asserted-by":"publisher","first-page":"653852","DOI":"10.3389\/fphar.2021.653852","volume":"12","author":"HJ Lu","year":"2021","unstructured":"Lu HJ, Fu YY, Wei QQ, Zhang ZJ (2021) Neuroinflammation in HIV-related neuropathic pain. Front Pharmacol 12:653852. https:\/\/doi.org\/10.3389\/fphar.2021.653852","journal-title":"Front Pharmacol"},{"issue":"3","key":"9981_CR70","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/WCO.0000000000000807","volume":"33","author":"JC McArthur","year":"2020","unstructured":"McArthur JC, Johnson TP (2020) Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies. Curr Opin Neurol 33(3):397\u2013404. https:\/\/doi.org\/10.1097\/WCO.0000000000000807","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"9981_CR71","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","volume":"12","author":"MD de Jong","year":"2006","unstructured":"de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, do Ha Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12(10):1203\u20131207. https:\/\/doi.org\/10.1038\/nm1477","journal-title":"Nat Med"},{"key":"9981_CR72","doi-asserted-by":"publisher","unstructured":"Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, Wang G (2021) The mechanism behind influenza virus cytokine storm. Viruses 13(7). https:\/\/doi.org\/10.3390\/v13071362","DOI":"10.3390\/v13071362"},{"key":"9981_CR73","doi-asserted-by":"publisher","first-page":"27912","DOI":"10.1038\/srep27912","volume":"6","author":"MD Tate","year":"2016","unstructured":"Tate MD, Ong JDH, Dowling JK, McAuley JL, Robertson AB, Latz E, Drummond GR, Cooper MA, Hertzog PJ, Mansell A (2016) Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition. Sci Rep 6:27912. https:\/\/doi.org\/10.1038\/srep27912","journal-title":"Sci Rep"},{"issue":"3","key":"9981_CR74","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/QCO.0000000000000451","volume":"31","author":"JR Radke","year":"2018","unstructured":"Radke JR, Cook JL (2018) Human adenovirus infections: update and consideration of mechanisms of viral persistence. Curr Opin Infect Dis 31(3):251\u2013256. https:\/\/doi.org\/10.1097\/QCO.0000000000000451","journal-title":"Curr Opin Infect Dis"},{"key":"9981_CR75","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/1743-422X-10-358","volume":"10","author":"A Bagashev","year":"2013","unstructured":"Bagashev A, Sawaya BE (2013) Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virol J 10:358. https:\/\/doi.org\/10.1186\/1743-422X-10-358","journal-title":"Virol J"},{"key":"9981_CR76","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbi.2020.07.026","volume":"89","author":"VS Alves","year":"2020","unstructured":"Alves VS, Leite-Aguiar R, Silva JPD, Coutinho-Silva R, Savio LEB (2020) Purinergic signaling in infectious diseases of the central nervous system. Brain Behav Immun 89:480\u2013490. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.026","journal-title":"Brain Behav Immun"},{"issue":"5209","key":"9981_CR77","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1126\/science.7716549","volume":"268","author":"CJ Li","year":"1995","unstructured":"Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB (1995) Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268(5209):429\u2013431. https:\/\/doi.org\/10.1126\/science.7716549","journal-title":"Science"},{"issue":"24","key":"9981_CR78","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1093\/emboj\/cdf683","volume":"21","author":"D Chen","year":"2002","unstructured":"Chen D, Wang M, Zhou S, Zhou Q (2002) HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J 21(24):6801\u20136810. https:\/\/doi.org\/10.1093\/emboj\/cdf683","journal-title":"EMBO J"},{"issue":"5305","key":"9981_CR79","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","volume":"275","author":"M Ott","year":"1997","unstructured":"Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, McCloskey T, Pahwa S, Verdin E (1997) Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275(5305):1481\u20131485. https:\/\/doi.org\/10.1126\/science.275.5305.1481","journal-title":"Science"},{"issue":"1","key":"9981_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/j.pain.0000000000001365","volume":"160","author":"J Scholz","year":"2019","unstructured":"Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S, First M, Giamberardino MA, Hansson P, Kaasa S, Korwisi B, Kosek E, Lavand\u2019homme P, Nicholas M et al (2019) the IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain 160(1):53\u201359. https:\/\/doi.org\/10.1097\/j.pain.0000000000001365","journal-title":"Pain"},{"issue":"14","key":"9981_CR81","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","volume":"21","author":"SB Oh","year":"2001","unstructured":"Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21(14):5027\u20135035. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-14-05027.2001","journal-title":"J Neurosci"},{"issue":"19","key":"9981_CR82","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.1128\/JVI.01158-14","volume":"88","author":"TH Swartz","year":"2014","unstructured":"Swartz TH, Esposito AM, Durham ND, Hartmann BM, Chen BK (2014) P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J Virol 88(19):11504\u201311515. https:\/\/doi.org\/10.1128\/JVI.01158-14","journal-title":"J Virol"},{"issue":"9","key":"9981_CR83","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.4049\/jimmunol.1102482","volume":"188","author":"JE Hazleton","year":"2012","unstructured":"Hazleton JE, Berman JW, Eugenin EA (2012) Purinergic receptors are required for HIV-1 infection of primary human macrophages. J Immunol 188(9):4488\u20134495. https:\/\/doi.org\/10.4049\/jimmunol.1102482","journal-title":"J Immunol"},{"key":"9981_CR84","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.coph.2019.02.006","volume":"47","author":"F Graziano","year":"2019","unstructured":"Graziano F, Vicenzi E, Poli G (2019) The ATP\/P2X7 axis in human immunodeficiency virus infection of macrophages. Curr Opin Pharmacol 47:46\u201352. https:\/\/doi.org\/10.1016\/j.coph.2019.02.006","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"9981_CR85","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bj.2019.05.007","volume":"42","author":"J Benzaquen","year":"2019","unstructured":"Benzaquen J, Heeke S, Janho Dit Hreich S, Douguet L, Marquette CH, Hofman P, Vouret-Craviari V (2019) Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: myth or reality? Biom J 42(3):141\u2013154. https:\/\/doi.org\/10.1016\/j.bj.2019.05.007","journal-title":"Biom J"},{"issue":"7","key":"9981_CR86","doi-asserted-by":"publisher","first-page":"e0158304","DOI":"10.1371\/journal.pone.0158304","volume":"11","author":"R Marci","year":"2016","unstructured":"Marci R, Gentili V, Bortolotti D, Lo Monte G, Caselli E, Bolzani S, Rotola A, Di Luca D, Rizzo R (2016) Presence of HHV-6A in endometrial epithelial cells from women with primary unexplained infertility. PLoS One 11(7):e0158304. https:\/\/doi.org\/10.1371\/journal.pone.0158304","journal-title":"PLoS One"},{"issue":"4","key":"9981_CR87","doi-asserted-by":"publisher","first-page":"e13174","DOI":"10.1111\/aji.13174","volume":"82","author":"D Bortolotti","year":"2019","unstructured":"Bortolotti D, Gentili V, Rotola A, Cultrera R, Marci R, Di Luca D, Rizzo R (2019) HHV-6A infection of endometrial epithelial cells affects immune profile and trophoblast invasion. Am J Reprod Immunol 82(4):e13174. https:\/\/doi.org\/10.1111\/aji.13174","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"9981_CR88","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12939-020-01162-y","volume":"19","author":"DN Poole","year":"2020","unstructured":"Poole DN, Escudero DJ, Gostin LO, Leblang D, Talbot EA (2020) Responding to the COVID-19 pandemic in complex humanitarian crises. Int J Equity Health 19(1):41. https:\/\/doi.org\/10.1186\/s12939-020-01162-y","journal-title":"Int J Equity Health"},{"key":"9981_CR89","unstructured":"WHO (2023) WHO COVID-19 dashboard 2020. World Health Organization, Geneva. Available online: https:\/\/covid19.who.int\/. Accessed 21 Jun 2023"},{"key":"9981_CR90","doi-asserted-by":"publisher","first-page":"1009393","DOI":"10.3389\/fpubh.2022.1009393","volume":"10","author":"S Naseer","year":"2022","unstructured":"Naseer S, Khalid S, Parveen S, Abbass K, Song H, Achim MV (2022) COVID-19 outbreak: impact on global economy. Front Public Health 10:1009393. https:\/\/doi.org\/10.3389\/fpubh.2022.1009393","journal-title":"Front Public Health"},{"key":"9981_CR91","doi-asserted-by":"publisher","first-page":"894470","DOI":"10.3389\/fimmu.2022.894470","volume":"13","author":"J Garcia-Villalba","year":"2022","unstructured":"Garcia-Villalba J, Hurtado-Navarro L, Penin-Franch A, Molina-Lopez C, Martinez-Alarcon L, Angosto-Bazarra D, Baroja-Mazo A, Pelegrin P (2022) Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity. Front Immunol 13:894470. https:\/\/doi.org\/10.3389\/fimmu.2022.894470","journal-title":"Front Immunol"},{"issue":"6585","key":"9981_CR92","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","volume":"375","author":"M Merad","year":"2022","unstructured":"Merad M, Blish CA, Sallusto F, Iwasaki A (2022) The immunology and immunopathology of COVID-19. Science 375(6585):1122\u20131127. https:\/\/doi.org\/10.1126\/science.abm8108","journal-title":"Science"},{"issue":"2","key":"9981_CR93","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, Li WW, Li VW, Mentzer SJ, Jonigk D (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med 383(2):120\u2013128. https:\/\/doi.org\/10.1056\/NEJMoa2015432","journal-title":"N Engl J Med"},{"issue":"4","key":"9981_CR94","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s15010-021-01603-y","volume":"49","author":"P Pagliano","year":"2021","unstructured":"Pagliano P, Sellitto C, Conti V, Ascione T, Esposito S (2021) Characteristics of viral pneumonia in the COVID-19 era: an update. Infection 49(4):607\u2013616. https:\/\/doi.org\/10.1007\/s15010-021-01603-y","journal-title":"Infection"},{"key":"9981_CR95","doi-asserted-by":"publisher","first-page":"904419","DOI":"10.3389\/fimmu.2022.904419","volume":"13","author":"D Ferrari","year":"2022","unstructured":"Ferrari D, Rubini M, Burns JS (2022) The potential of purinergic signaling to thwart viruses including SARS-CoV-2. Front Immunol 13:904419. https:\/\/doi.org\/10.3389\/fimmu.2022.904419","journal-title":"Front Immunol"},{"issue":"4","key":"9981_CR96","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00109-022-02185-4","volume":"100","author":"GB da Silva","year":"2022","unstructured":"da Silva GB, Manica D, da Silva AP, Kosvoski GC, Hanauer M, Assmann CE, Simoes JLB, Pillat MM, de Lara JD, Marafon F, Bertollo AG, Mingoti MED, Gavioli J, Reus GZ, de Oliveira GG, Ignacio ZM, Bagatini MD (2022) High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity. J Mol Med (Berl) 100(4):645\u2013663. https:\/\/doi.org\/10.1007\/s00109-022-02185-4","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"9981_CR97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/cts.13475","volume":"16","author":"ARR Vicentino","year":"2023","unstructured":"Vicentino ARR, Fraga-Junior VDS, Palazzo M, Tasmo NRA, Rodrigues DAS, Barroso SPC, Ferreira SN, Neves-Borges AC, Allonso D, Fantappie MR, Scharfstein J, Oliveira AC, Vianna-Jorge R, Vale AM, Coutinho-Silva R, Savio LEB, Canetti C, Benjamim CF (2023) High mobility group box 1, ATP, lipid mediators, and tissue factor are elevated in COVID-19 patients: HMGB1 as a biomarker of worst prognosis. Clin Transl Sci 16(4):631\u2013646. https:\/\/doi.org\/10.1111\/cts.13475","journal-title":"Clin Transl Sci"},{"key":"9981_CR98","doi-asserted-by":"publisher","first-page":"1012027","DOI":"10.3389\/fimmu.2022.1012027","volume":"13","author":"AJ Pietrobon","year":"2022","unstructured":"Pietrobon AJ, Andrejew R, Custodio RWA, Oliveira LM, Scholl JN, Teixeira FME, de Brito CA, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo T, Aoki V, Figueiro F, Battastini AM, Ulrich H, Benard G, Duarte A, Sato MN (2022) Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients. Front Immunol 13:1012027. https:\/\/doi.org\/10.3389\/fimmu.2022.1012027","journal-title":"Front Immunol"},{"issue":"1","key":"9981_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11302-021-09839-x","volume":"19","author":"XM Wu","year":"2023","unstructured":"Wu XM, Zhang N, Li JS, Yang ZH, Huang XL, Yang XF (2023) Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis. Purinergic Signal 19(1):265\u2013272. https:\/\/doi.org\/10.1007\/s11302-021-09839-x","journal-title":"Purinergic Signal"},{"key":"9981_CR100","doi-asserted-by":"publisher","unstructured":"Strassheim D, Verin A, Batori R, Nijmeh H, Burns N, Kovacs-Kasa A, Umapathy NS, Kotamarthi J, Gokhale YS, Karoor V, Stenmark KR, Gerasimovskaya E (2020) P2Y purinergic receptors, endothelial dysfunction, and cardiovascular diseases. Int J Mol Sci 21(18). https:\/\/doi.org\/10.3390\/ijms21186855","DOI":"10.3390\/ijms21186855"},{"issue":"12","key":"9981_CR101","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1172\/JCI87343","volume":"126","author":"S Wang","year":"2016","unstructured":"Wang S, Chennupati R, Kaur H, Iring A, Wettschureck N, Offermanns S (2016) Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J Clin Invest 126(12):4527\u20134536. https:\/\/doi.org\/10.1172\/JCI87343","journal-title":"J Clin Invest"},{"issue":"8","key":"9981_CR102","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1172\/JCI81067","volume":"125","author":"S Wang","year":"2015","unstructured":"Wang S, Iring A, Strilic B, Albarran Juarez J, Kaur H, Troidl K, Tonack S, Burbiel JC, Muller CE, Fleming I, Lundberg JO, Wettschureck N, Offermanns S (2015) P2Y(2) and Gq\/G(1)(1) control blood pressure by mediating endothelial mechanotransduction. J Clin Invest 125(8):3077\u20133086. https:\/\/doi.org\/10.1172\/JCI81067","journal-title":"J Clin Invest"},{"issue":"4","key":"9981_CR103","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1182\/blood-2007-10-117044","volume":"111","author":"T Eckle","year":"2008","unstructured":"Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111(4):2024\u20132035. https:\/\/doi.org\/10.1182\/blood-2007-10-117044","journal-title":"Blood"},{"issue":"14","key":"9981_CR104","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","volume":"95","author":"J Jin","year":"1998","unstructured":"Jin J, Kunapuli SP (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A 95(14):8070\u20138074. https:\/\/doi.org\/10.1073\/pnas.95.14.8070","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9981_CR105","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.thromres.2013.08.021","volume":"132","author":"M Aslam","year":"2013","unstructured":"Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gunduz D (2013) Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y(1) and P2Y(1)(2) receptors. Thromb Res 132(5):548\u2013557. https:\/\/doi.org\/10.1016\/j.thromres.2013.08.021","journal-title":"Thromb Res"},{"issue":"4","key":"9981_CR106","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","volume":"67","author":"LEB Savio","year":"2017","unstructured":"Savio LEB, de Andrade MP, Figliuolo VR, de Avelar Almeida TF, Santana PT, Oliveira SDS, Silva CLM, Feldbrugge L, Csizmadia E, Minshall RD, Longhi MS, Wu Y, Robson SC, Coutinho-Silva R (2017) CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol 67(4):716\u2013726. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.021","journal-title":"J Hepatol"},{"issue":"2","key":"9981_CR107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11302-012-9342-3","volume":"9","author":"V Roberts","year":"2013","unstructured":"Roberts V, Lu B, Rajakumar S, Cowan PJ, Dwyer KM (2013) The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury. Purinergic Signal 9(2):135\u2013143. https:\/\/doi.org\/10.1007\/s11302-012-9342-3","journal-title":"Purinergic Signal"},{"issue":"1","key":"9981_CR108","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12931-023-02486-3","volume":"24","author":"T Kelestemur","year":"2023","unstructured":"Kelestemur T, Nemeth ZH, Pacher P, Beesley J, Robson SC, Eltzschig HK, Hasko G (2023) Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering A(2B)R signaling. Respir Res 24(1):186. https:\/\/doi.org\/10.1186\/s12931-023-02486-3","journal-title":"Respir Res"},{"issue":"1","key":"9981_CR109","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L (2023) CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer 22(1):44. https:\/\/doi.org\/10.1186\/s12943-023-01733-x","journal-title":"Mol Cancer"},{"issue":"5","key":"9981_CR110","doi-asserted-by":"publisher","first-page":"e0197151","DOI":"10.1371\/journal.pone.0197151","volume":"13","author":"F Raczkowski","year":"2018","unstructured":"Raczkowski F, Rissiek A, Ricklefs I, Heiss K, Schumacher V, Wundenberg K, Haag F, Koch-Nolte F, Tolosa E, Mittrucker HW (2018) CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes. PLoS One 13(5):e0197151. https:\/\/doi.org\/10.1371\/journal.pone.0197151","journal-title":"PLoS One"},{"key":"9981_CR111","doi-asserted-by":"publisher","unstructured":"Elsaghir A, El-Sabaa EMW, Ahmed AK, Abdelwahab SF, Sayed IM, El-Mokhtar MA (2023) The role of cluster of differentiation 39 (CD39) and purinergic signaling pathway in viral infections. Pathogens 12(2). https:\/\/doi.org\/10.3390\/pathogens12020279","DOI":"10.3390\/pathogens12020279"},{"key":"9981_CR112","doi-asserted-by":"publisher","first-page":"847894","DOI":"10.3389\/fimmu.2022.847894","volume":"13","author":"E Diaz-Garcia","year":"2022","unstructured":"Diaz-Garcia E, Garcia-Tovar S, Alfaro E, Zamarron E, Mangas A, Galera R, Ruiz-Hernandez JJ, Sole-Violan J, Rodriguez-Gallego C, Van-Den-Rym A, Perez-de-Diego R, Nanwani-Nanwani K, Lopez-Collazo E, Garcia-Rio F, Cubillos-Zapata C (2022) Role of CD39 in COVID-19 severity: dysregulation of purinergic signaling and thromboinflammation. Front Immunol 13:847894. https:\/\/doi.org\/10.3389\/fimmu.2022.847894","journal-title":"Front Immunol"},{"issue":"8","key":"9981_CR113","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1002\/jcp.30805","volume":"237","author":"GP Dorneles","year":"2022","unstructured":"Dorneles GP, Teixeira PC, da Silva IM, Schipper LL, Santana Filho PC, Rodrigues Junior LC, Bonorino C, Peres A, Fonseca SG, Monteiro MC, Boeck CR, Eller S, Oliveira TF, Wendland EM, Romao PRT (2022) Alterations in CD39\/CD73 axis of T cells associated with COVID-19 severity. J Cell Physiol 237(8):3394\u20133407. https:\/\/doi.org\/10.1002\/jcp.30805","journal-title":"J Cell Physiol"},{"issue":"1","key":"9981_CR114","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/09537104.2010.497231","volume":"22","author":"S Kim","year":"2011","unstructured":"Kim S, Kunapuli SP (2011) P2Y12 receptor in platelet activation. Platelets 22(1):56\u201360. https:\/\/doi.org\/10.3109\/09537104.2010.497231","journal-title":"Platelets"},{"issue":"10","key":"9981_CR115","doi-asserted-by":"publisher","first-page":"103205","DOI":"10.1016\/j.isci.2021.103205","volume":"24","author":"N Wang","year":"2021","unstructured":"Wang N, Vuerich M, Kalbasi A, Graham JJ, Csizmadia E, Manickas-Hill ZJ, Woolley A, David C, Miller EM, Gorman K, Hecht JL, Shaefi S, Robson SC, Longhi MS (2021) Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19. iScience 24(10):103205. https:\/\/doi.org\/10.1016\/j.isci.2021.103205","journal-title":"iScience"},{"issue":"3","key":"9981_CR116","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.celrep.2023.112189","volume":"42","author":"FL Fontes-Dantas","year":"2023","unstructured":"Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, Mota-Araujo HP, Colodeti LC, Araujo SMB, Froz GM, da Silva TN, Duarte LA, Salvio AL, Pires KL, Leon LAA, Vasconcelos CCF, Romao L, Savio LEB, Silva JL et al (2023) SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep 42(3):112189. https:\/\/doi.org\/10.1016\/j.celrep.2023.112189","journal-title":"Cell Rep"},{"key":"9981_CR117","doi-asserted-by":"publisher","unstructured":"Illes P, Rubini P, Ulrich H, Zhao Y, Tang Y (2020) Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells 9(5). https:\/\/doi.org\/10.3390\/cells9051108","DOI":"10.3390\/cells9051108"},{"key":"9981_CR118","doi-asserted-by":"publisher","first-page":"1158460","DOI":"10.3389\/fimmu.2023.1158460","volume":"14","author":"VS Alves","year":"2023","unstructured":"Alves VS, Santos S, Leite-Aguiar R, Paiva-Pereira E, Dos Reis RR, Calazans ML, Fernandes GG, Antonio LS, de Lima EV, Kurtenbach E, Silva JL, Fontes-Dantas FL, Passos GF, Figueiredo CP, Coutinho-Silva R, Savio LEB (2023) SARS-CoV-2 Spike protein alters microglial purinergic signaling. Front Immunol 14:1158460. https:\/\/doi.org\/10.3389\/fimmu.2023.1158460","journal-title":"Front Immunol"},{"issue":"21","key":"9981_CR119","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1111\/bph.15138","volume":"177","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, Tang Y, Sarti AC, Rossato M (2020) A rationale for targeting the P2X7 receptor in Coronavirus disease 19. Br J Pharmacol 177(21):4990\u20134994. https:\/\/doi.org\/10.1111\/bph.15138","journal-title":"Br J Pharmacol"},{"key":"9981_CR120","doi-asserted-by":"publisher","first-page":"110012","DOI":"10.1016\/j.mehy.2020.110012","volume":"144","author":"MA Abouelkhair","year":"2020","unstructured":"Abouelkhair MA (2020) Targeting adenosinergic pathway and adenosine A(2A) receptor signaling for the treatment of COVID-19: a hypothesis. Med Hypotheses 144:110012. https:\/\/doi.org\/10.1016\/j.mehy.2020.110012","journal-title":"Med Hypotheses"},{"issue":"8","key":"9981_CR121","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s11010-021-04130-4","volume":"476","author":"MLM Franciosi","year":"2021","unstructured":"Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM (2021) Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 476(8):2891\u20132898. https:\/\/doi.org\/10.1007\/s11010-021-04130-4","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"9981_CR122","doi-asserted-by":"publisher","first-page":"s33","DOI":"10.1161\/ATVBAHA.107.160689","volume":"28","author":"AD Michelson","year":"2008","unstructured":"Michelson AD (2008) P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol 28(3):s33\u2013s38. https:\/\/doi.org\/10.1161\/ATVBAHA.107.160689","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9981_CR123","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","volume":"8","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signalling: therapeutic developments. Front Pharmacol 8:661. https:\/\/doi.org\/10.3389\/fphar.2017.00661","journal-title":"Front Pharmacol"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-023-09981-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09981-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T01:20:26Z","timestamp":1743643226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-023-09981-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["9981"],"URL":"https:\/\/doi.org\/10.1007\/s11302-023-09981-8","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}